docetaxel anhydrous has been researched along with ngr peptide in 4 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (ngr peptide) | Trials (ngr peptide) | Recent Studies (post-2010) (ngr peptide) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 117 | 2 | 95 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Wang, J; Wang, X; Wang, Y; Zhang, Q; Zhang, X | 1 |
| Li, M; Lu, C; Shi, J; Wang, L; Zhang, H; Zhang, M; Zhang, N; Zhang, Z | 1 |
| Agrawal, GP; Chashoo, G; Gupta, M; Gupta, PN; Saxena, AK; Sharma, PR; Vyas, SP | 1 |
| Chang, M; Fan, Y; Gu, Z; Lin, G; Shi, Y | 1 |
4 other study(ies) available for docetaxel anhydrous and ngr peptide
| Article | Year |
|---|---|
NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; CD13 Antigens; Cell Line, Tumor; Chemistry, Pharmaceutical; Docetaxel; Drug Compounding; Drug Stability; Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Microscopy, Confocal; Oligopeptides; Particle Size; Taxoids; Temperature; Xenograft Model Antitumor Assays | 2009 |
Synergistic enhancement of cancer therapy using a combination of docetaxel and photothermal ablation induced by single-walled carbon nanotubes.
Topics: Ablation Techniques; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Docetaxel; Drug Carriers; Female; Humans; Laser Therapy; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Nanotubes, Carbon; Neoplasms, Experimental; Oligopeptides; Surface-Active Agents; Taxoids; Xenograft Model Antitumor Assays | 2011 |
Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.
Topics: Animals; Antineoplastic Agents; Apoptosis; CD13 Antigens; Cell Cycle; Cell Proliferation; Cells, Cultured; Docetaxel; Drug Carriers; Drug Delivery Systems; Fibrosarcoma; Flow Cytometry; Hemolysis; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Macrophages; Mice; Mice, Inbred BALB C; Nanoparticles; Oligopeptides; Phagocytosis; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Taxoids; Tissue Distribution | 2014 |
NGR-modified pH-sensitive liposomes for controlled release and tumor target delivery of docetaxel.
Topics: Animals; Cell Line, Tumor; Cholesterol Esters; Delayed-Action Preparations; Docetaxel; Drug Delivery Systems; Drug Liberation; Humans; Hydrogen-Ion Concentration; Liposomes; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Oligopeptides; Polyethylene Glycols; Taxoids; Xenograft Model Antitumor Assays | 2017 |